Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10045141HBVENSG00000110799.14protein_codingVWFNoNo7450P04275
TVIS10045142HBVENSG00000110799.14protein_codingVWFNoNo7450P04275
TVIS30078176HIVENSG00000110799.14protein_codingVWFNoNo7450P04275
TVIS30031856HIVENSG00000110799.14protein_codingVWFNoNo7450P04275
TVIS20031407HPVENSG00000110799.14protein_codingVWFNoNo7450P04275
TVIS44014045HTLV-1ENSG00000110799.14protein_codingVWFNoNo7450P04275
TVIS44017512HTLV-1ENSG00000110799.14protein_codingVWFNoNo7450P04275
TCGA Plot Options
Drug Information
GeneVWF
DrugBank IDDB09329
Drug NameAntihemophilic factor (recombinant), PEGylated
Target IDBE0001043
UniProt IDP04275
Regulation Typebinder
PubMed IDs6424437; 23398640
CitationsChavin SI: Factor VIII: structure and function in blood clotting. Am J Hematol. 1984 Apr;16(3):297-306.@@Tiede A, Brand B, Fischer R, Kavakli K, Lentz SR, Matsushita T, Rea C, Knobe K, Viuff D: Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A. J Thromb Haemost. 2013 Apr;11(4):670-8. doi: 10.1111/jth.12161.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBL